Dupilumab-related adverse events among patients with chronic rhinosinusitis with nasal polyposis

Int Forum Allergy Rhinol. 2023 Aug;13(8):1542-1545. doi: 10.1002/alr.23108. Epub 2022 Nov 29.

Authors

Daniel J Lee¹, Hannah B Cramer¹, Rijul S Kshirsagar², Jennifer E Douglas¹, Michael A Kohanski¹, James N Palmer¹, Nithin D Adappa¹, John V Bosso¹

Affiliations

¹ Department of Otorhinolaryngology-Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
² Department of Head and Neck Surgery, Kaiser Permanente Redwood City Medical Center, Redwood City, California, USA.

PMID: 36394542
DOI: 10.1002/alr.23108

No abstract available

Keywords: adverse; autoimmune reaction; dupilumab; event; severe.

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Chronic Disease
Humans
Nasal Polyps* / drug therapy
Rhinitis* / drug therapy
Sinusitis* / drug therapy
Sinusitis* / epidemiology

Substances

dupilumab
Antibodies, Monoclonal, Humanized